influenza
viru
iav
infect
respiratori
tract
human
caus
signific
morbid
mortal
worldwid
year
aggress
inflamm
known
cytokin
storm
thought
caus
damag
lung
iav
infect
dysfunct
coagul
common
complic
pathogen
influenza
manifest
lung
endotheli
activ
vascular
leak
dissemin
intravascular
coagul
pulmonari
microembol
importantli
emerg
evid
show
uncontrol
coagul
system
includ
cellular
endotheli
cell
platelet
protein
coagul
factor
anticoagul
fibrinolysi
proteas
compon
contribut
pathogenesi
influenza
augment
viral
replic
immun
pathogenesi
review
focu
underli
mechan
dysfunct
coagulatori
respons
pathogenesi
iav
influenza
viru
iav
genu
famili
orthomyxovirida
contain
negativesens
singlestrand
segment
rna
genom
categor
subtyp
base
express
hemagglutinin
ha
neuraminidas
na
surfac
viral
envelop
season
flu
caus
differ
subtyp
iav
usual
lead
death
half
million
peopl
year
pandem
flu
caus
genet
reassort
transmiss
iav
chain
wild
birdspoultrypig
becom
one
immin
danger
human
be
lack
immun
memori
zoonot
virus
often
caus
high
morbid
mortal
infect
peopl
exampl
notori
pandem
kill
million
peopl
global
pandem
death
toll
peopl
sever
iav
involv
either
season
pandem
influenza
viru
infect
upper
respiratori
tract
induc
acut
respiratori
distress
syndrom
ard
clinic
characterist
alveolar
chang
influenza
viru
pneumonia
includ
capillari
thrombosi
focal
necrosi
hyperemia
alveolar
wall
inflammatori
infiltr
format
hyalin
membran
pulmonari
edema
small
vessel
thrombosi
hemorrhag
diffus
alveolar
damag
observ
sever
influenza
pneumonia
indic
disord
coagul
sever
iav
also
caus
multipl
organ
dysfunct
syndrom
dissemin
intravascular
coagul
dic
iav
primarili
target
airway
alveolar
epitheli
cell
bind
sialic
acid
residu
ha
intern
viral
rna
cytosol
activ
pattern
recognit
receptor
includ
tolllik
receptor
tlr
primarili
retino
acid
induc
rigi
initi
innat
immun
respons
recognit
viral
rna
rigi
tlr
activ
induc
robust
type
iii
interferon
respons
induc
transcript
releas
hundr
interferonstimul
gene
isg
trigger
activ
nuclear
factor
kappa
b
induc
product
proinflammatori
cytokin
chemokin
exampl
interleukin
il
rant
addit
viral
rna
protein
also
activ
inflammasom
result
releas
ifn
proinflammatori
cytokin
chemokin
import
viral
clearanc
also
induc
recruit
activ
circul
neutrophil
monocyt
lymphocyt
natur
killer
nk
cell
natur
killer
cell
cell
site
infect
addit
activ
innat
immun
respons
prime
adapt
immun
respons
erad
viru
innat
immun
cell
often
overactiv
iavinduc
ard
contribut
high
morbid
mortal
overproduct
proinflammatori
cytokin
overactiv
immun
cell
iav
infect
known
cytokin
storm
although
gener
concept
cytokin
storm
well
known
review
ref
precis
constitut
molecular
mechan
iavassoci
hyperinflammatori
respons
ard
larg
unclear
emerg
line
evid
indic
aggress
immun
respons
sever
influenza
augment
dysfunct
coagul
manifest
lung
endotheli
activ
vascular
leak
dissemin
intravascular
coagul
pulmonari
microembol
review
summar
recent
advanc
understand
hyperinflammatori
respons
caus
aberr
coagul
iav
infect
coagul
format
blood
clot
coagul
highli
order
process
involv
three
compon
endotheli
cell
platelet
coagul
factor
sequenti
action
primari
hemostasi
secondari
hemostasi
fibrinolysi
typic
coagul
initi
injuri
vascular
endotheli
cell
ec
figur
primari
hemostasi
character
platelet
bind
injur
andor
activ
ec
immedi
format
platelet
plug
figur
secondari
coagul
two
separ
initi
pathway
contact
activ
pathway
intrins
pathway
tissu
factor
tf
pathway
extrins
pathway
figur
e
pathway
result
figur
cascad
coagul
system
rest
ec
provid
natur
anticoagul
tm
tfpi
adpas
inhibit
coagul
keep
platelet
activ
coagul
cascad
check
b
coagul
typic
initi
injuri
vascular
ec
result
exposur
tf
collagen
subendotheli
tissu
blood
releas
vwf
c
platelet
activ
expos
tf
collagen
vwf
activ
platelet
releas
number
mediat
adp
vwf
store
within
granul
lead
platelet
recruit
activ
aggreg
plug
format
process
term
primari
hemostasi
interact
tf
factor
vii
initi
extrins
pathway
e
exposur
collagen
blood
start
intrins
pathway
f
extrins
intrins
pathway
result
initi
common
pathway
contain
cascad
involv
product
activ
factor
x
thrombin
format
fibrin
strand
g
fibrin
strand
strengthen
platelet
plug
lead
format
stabl
plateletfibrin
clot
process
term
secondari
hemostasi
h
kallikrein
upa
tpa
activ
plasminogen
plasmin
degrad
reabsorb
polymer
fibrin
strand
eventu
process
fibrinolysi
heal
wound
antithrombin
ec
endotheli
cell
tf
tissu
factor
tfpi
tissu
factor
pathway
inhibitor
tm
thrombomodulin
tpa
tissu
plasminogen
activ
upa
urokinas
plasminogen
activ
vwf
von
willebrand
factor
product
factor
x
induc
thrombin
format
fibrin
strand
strengthen
platelet
plug
form
stabl
plateletfibrin
clot
figur
g
coagul
process
tightli
control
anticoagul
limit
clot
avoid
thrombu
propag
fibrinolysi
respons
degrad
plateletfibrin
clot
wound
heal
figur
h
thrombosi
often
lead
hemorrhag
common
clinic
complic
sever
influenza
patient
sever
iav
infect
viral
infect
often
show
typic
alter
coagul
includ
hyperemia
alveolar
wall
pulmonari
capillari
small
vessel
thrombosi
fibrin
deposit
dic
hemorrhag
coagul
abnorm
coagulopathi
character
prolong
activ
partial
thromboplastin
time
prothrombin
time
thrombin
time
decreas
platelet
count
blood
patient
infect
highli
pathogen
thrombot
hemorrhag
complic
report
influenza
swine
flu
microscop
thrombi
thromboemboli
pulmonari
arteri
thrombi
pulmonari
hemorrhag
hemoptysi
hematemesi
petechi
rash
thu
influenza
viru
infect
result
disord
includ
overactiv
coagul
lead
uncontrol
thrombosi
coagulopathi
lead
pulmonari
hemorrhag
edema
overactiv
coagul
influenza
exacerb
risk
pulmonari
cardiac
diseas
iav
infect
also
caus
transient
increas
risk
deep
venou
thrombosi
pulmonari
embol
acut
coronari
syndrom
acut
cardiac
injuri
acut
myocardi
infarct
ami
cardiovascular
diseas
exampl
infect
elev
express
gene
promot
hemostasi
andor
platelet
aggreg
signatur
platelet
gene
associ
ami
acut
thrombosi
alreadydiseas
coronari
arteri
caus
subcrit
level
stenosi
attribut
develop
acut
coronari
syndrom
therefor
reduc
risk
infect
vaccin
influenza
effect
reduc
risk
stroke
hospit
ami
rate
cardiovascular
event
benefici
cardiovascular
outcom
increas
surviv
among
patient
acut
heart
failur
clinic
trial
use
oseltamivir
tamiflu
shown
reduct
viral
load
associ
decreas
incid
cardiac
disord
anim
studi
partli
explain
mechan
activ
coagul
iav
infect
iav
activ
coagul
increas
thrombin
gener
fibrin
deposit
fibrinolysi
mice
ddimer
circul
marker
enhanc
coagul
fibrinolysi
concentr
von
willebrand
factor
vwf
activ
increas
ferret
infect
season
pandem
highli
pathogen
avian
influenza
hpai
virus
activ
marker
coagul
thrombinantithrombin
complex
increas
pandem
virusinfect
ferret
intracapillari
fibrin
deposit
especi
evid
infect
importantli
prothrombot
state
induc
influenza
viru
infect
inevit
downregul
anticoagul
compon
inhibit
fibrinolysi
turn
abnorm
coagul
promot
hemorrhag
thrombosi
often
associ
overzeal
inflamm
observ
sever
iav
infect
rest
ec
provid
nonthrombogen
barrier
prevent
inappropri
activ
coagul
produc
numer
anticoagul
compon
inhibit
platelet
activ
figur
activ
injur
ec
initi
coagul
activ
platelet
express
coagul
compon
well
downregul
physiolog
anticoagul
compon
suppress
fibrinolyt
activ
figur
time
activ
ec
result
increas
local
blood
circul
local
plasma
leakag
recruit
activ
leukocyt
promot
inflamm
iav
directli
indirectli
induc
ec
activ
vascular
hyperperm
figur
certain
iav
subtyp
may
infect
lung
endotheli
cell
also
express
sialic
acid
adjac
primari
target
cell
respiratori
epithelia
recognit
damageassoci
molecular
pattern
oxid
phospholipid
via
also
activ
ec
drive
lung
injuri
direct
stimul
viral
rna
result
upregul
tf
downregul
thrombomodulin
endotheli
cell
human
iav
report
induc
pulmonari
microvascular
leakag
degrad
tight
junction
protein
vivo
ddimer
tissu
fibrin
deposit
elev
inflammatori
cytokin
produc
leukocyt
lung
epithelium
pulmonari
endothelium
mainli
contribut
endothelium
dysfunct
elev
level
shown
induc
ec
apoptosi
upregul
trypsin
ec
result
loss
zonula
tight
junction
protein
vascular
hyperperm
via
proteaseactiv
hypoxia
found
flu
patient
contribut
ec
activ
induc
releas
proinflammatori
plateletactiv
factor
paf
intercellular
adhes
molecul
pselectin
vwf
thu
iav
infect
induc
pulmonari
hemorrhag
alveolar
edema
activ
damag
ec
via
sever
mechan
includ
direct
damag
loss
tight
junction
hyperperm
induc
inflammatori
factor
apoptosi
endotheli
cell
time
activ
damag
ec
lead
activ
procoagulatori
cascad
express
tf
vwf
activ
ec
exposur
collagen
blood
result
disrupt
endotheli
barrier
increas
platelet
bind
ec
induc
platelet
activ
aggreg
activ
extrins
coagul
cascad
figur
ec
activ
reduc
express
secret
compon
anticoagul
fibrinolysi
facilit
microthrombosi
lung
impair
coagul
lead
dic
trigger
decompens
thrombocytopenia
induc
overactiv
excess
aggreg
passiv
exhaust
platelet
discuss
pulmonari
thrombosi
result
passiv
congest
limit
compensatori
ventil
respons
exacerb
vascular
leakag
alveolar
edema
contribut
widespread
hemorrhag
sever
hypoxia
multipl
organ
failur
death
sever
iav
infect
figur
pulmonari
ec
subsequ
play
crucial
role
initi
amplif
cytokin
storm
iav
infect
activ
signal
pulmonari
endothelium
receptor
agonist
inhibit
cytokin
storm
protect
host
pathogen
influenza
viru
challeng
moreov
signal
signal
necessari
earli
amplif
cytokin
storm
receptor
agonist
treatment
blunt
cytokin
storm
mainli
inhibit
signal
pathway
innat
cytokin
chemokin
product
innat
immun
cell
infiltr
separ
event
pulmonari
endothelium
center
process
innat
immun
cell
infiltr
regul
ec
express
adhes
decompens
thrombocytopenia
anoth
reason
hemorrhag
iav
infect
e
activ
platelet
act
proinflammatori
cell
releas
inflammatori
cytokin
promot
activ
transmigr
cytokin
releas
neutrophil
b
nk
cell
dc
monocyt
activ
platelet
also
modul
ec
function
promot
inflammatori
respons
f
cytokin
storm
overactiv
neutrophil
monocyt
lymphocyt
nk
cell
nkt
cell
cell
well
overproduct
inflammatori
cytokin
cell
contribut
high
morbid
mortal
iav
infect
antithrombin
damp
damageassoci
molecular
pattern
dc
dendrit
cell
ec
endotheli
cell
iav
influenza
viru
nk
natur
killer
nkt
natur
killer
cell
pamp
pathogenassoci
molecular
pattern
par
proteaseactiv
receptor
tf
tissu
factor
tfpi
tissu
factor
pathway
inhibitor
tm
thrombomodulin
vwf
von
willebrand
factor
molecul
pselectin
eselectin
facilit
bind
migrat
leukocyt
influenza
viru
infect
figur
activ
ecplateletleukocyt
interact
feed
forward
amplifi
overal
inflammatori
respons
figur
thu
pulmonari
ec
might
potenti
therapeut
target
critic
role
amplif
cytokin
storm
primari
function
platelet
sens
injur
vessel
endothelia
initi
blood
clot
hemostasi
recent
studi
show
addit
import
role
damag
repair
platelet
also
integr
part
innat
immun
system
proinflammatori
cell
activ
damag
ec
platelet
activ
numer
factor
includ
collagen
thromboxan
vwf
thrombin
adp
proinflammatori
cytokin
paf
figur
influenza
viru
also
activ
platelet
platelet
iggviru
immun
complex
moreov
activ
platelet
releas
number
mediat
cytokin
store
within
densegranul
platelet
recruit
activ
aggreg
figur
platelet
major
proinflammatori
cell
inflammatori
condit
upon
activ
platelet
chang
smooth
disc
spini
sphere
rapidli
releas
inflammatori
coagulatori
mediat
store
granul
express
number
receptor
adhes
clot
molecul
interact
pselectin
activ
platelet
pselectin
glycoprotein
ligand
express
neutrophil
lead
activ
neutrophil
circul
redistribut
guid
neutrophil
intravascular
crawl
transmigr
initi
inflamm
figur
plateletneutrophil
aggreg
contribut
varieti
inflammatori
set
includ
acut
lung
injuri
acut
hepat
injuri
sepsi
atherosclerosi
plateletneutrophil
aggreg
also
respons
gener
reactiv
oxygen
speci
ro
neutrophil
modul
phagocyt
capac
neutrophil
format
neutrophil
extracellular
trap
web
extracellular
dna
histon
activ
platelet
also
interact
cell
b
cell
nk
cell
dendrit
cell
dc
monocyt
induc
home
activ
recruit
cytokin
releas
figur
importantli
cytokin
chemokin
releas
activ
platelet
includ
profoundli
involv
modul
endotheli
cell
function
leukocyt
traffick
immun
respons
figur
exampl
releas
activ
platelet
activ
endotheli
cell
upregul
eselectin
pselectin
releas
tf
therebi
promot
leukocyt
recruit
lesion
immun
activ
massiv
infiltr
activ
aggreg
platelet
lung
may
associ
thrombocytopenia
often
observ
highli
pathogen
influenza
viru
infect
rare
human
virus
adenoviru
metapneumoviru
coronaviru
bocaviru
infect
thrombocytopenia
observ
patient
infect
avian
origin
risk
factor
acut
respiratori
failur
influenza
overactiv
platelet
influenza
virus
caus
thrombosi
lung
passiv
exhaust
platelet
lead
thrombocytopenia
therefor
blockad
platelet
overactiv
aggreg
reduc
sever
acut
respiratori
syndrom
exampl
administr
antagonist
inhibit
activ
platelet
induc
thrombin
decreas
inflamm
improv
surviv
iav
infect
mice
defici
major
platelet
receptor
glycoprotein
iiia
gpiiia
treatment
antiplatelet
compound
eptifibatid
mr
clopidogrel
acetylsalicyl
acidaspirin
ticlopidin
protect
mice
lethal
influenza
viru
infect
aspirin
also
act
antiinfluenza
viru
agent
vitro
inhibit
proinflammatori
activ
improv
influenza
outcom
vivo
howev
whether
aspirin
inhibit
platelet
activ
vivo
controversi
may
increas
mortal
pandem
influenza
influenza
viru
infect
anim
model
larger
scale
clinic
studi
need
exclud
strain
variat
influenza
virus
variou
antipyret
regim
model
metaanalysi
exampl
treatment
aspirin
dicrofenac
sodium
aggrav
hematogen
spread
iav
central
nervou
system
chicken
affect
transneur
infect
mice
interestingli
aspirin
significantli
increas
mortal
influenza
b
viru
mous
model
rey
syndrom
aspirin
acetaminophen
potenti
exacerb
consequ
influenza
b
viru
infect
neonat
mice
weanl
mice
therefor
antiplatelet
compound
explor
potenti
treatment
influenza
studi
need
data
must
care
interpret
plasma
coagul
cascad
primarili
initi
tf
influenza
infect
physiolog
condit
tf
present
subendotheli
tissu
fibroblast
circulatori
blood
cell
ec
express
tf
figur
inflamm
caus
iav
infect
caus
disrupt
vessel
wall
expos
tf
circul
ec
monocyt
begin
produc
tf
respons
variou
proinflammatori
cytokin
pathogenassoci
molecular
pattern
viral
rna
coagul
cascad
initi
quickli
tf
expos
blood
figur
activ
coagul
cascad
gener
thrombin
proteas
factor
iia
convert
fibrinogen
fibrin
figur
thrombin
involv
feedback
activ
coagul
activ
coagul
factor
v
viii
xi
xiii
figur
f
one
strongest
platelet
activ
thrombin
also
induc
platelet
aggreg
clot
format
furthermor
fibrinogen
fibrin
also
activ
macrophag
cytokin
product
addit
role
coagul
activ
coagulatori
factor
thrombin
fxa
fviia
also
augment
initi
inflammatori
respons
treatment
recombin
inhibitor
fviiatf
complex
attenu
proinflammatori
respons
prolong
surviv
rate
rhesu
monkey
model
ebola
hemorrhag
fever
proinflammatori
function
coagul
factor
mediat
activ
par
mainli
express
platelet
cell
type
includ
ec
macrophag
mast
cell
eosinophil
myocyt
gastrointestin
bronchial
epitheli
cell
activ
thrombin
wherea
activ
fviia
fxa
thrombin
also
respons
fxa
signal
par
signal
activ
ec
platelet
leukocyt
express
proinflammatori
cytokin
chemokin
increas
permeabl
ec
adhes
chemotaxi
leukocyt
figur
pathway
promot
deleteri
innat
inflammatori
respons
influenza
viru
infect
mice
play
protect
pathogen
role
respons
infect
activ
exacerb
acut
lung
injuri
inflamm
death
platelet
activ
antagonist
pepducin
protect
mice
influenza
viru
infect
taken
togeth
result
suggest
coagul
factor
mainli
play
pathogen
role
may
serv
therapeut
target
iav
infect
keep
platelet
activ
coagul
cascad
check
coagul
well
regul
three
major
anticoagul
mechan
protein
c
pc
antithrombin
tissu
factor
pathway
inhibitor
tfpi
figur
defici
anticoagul
may
result
acquir
thrombophilia
condit
increas
tendenc
form
blood
clot
pc
major
endogen
anticoagul
activ
thrombin
activ
pc
cleav
activ
fva
fviiia
inhibit
coagul
cascad
addit
anticoagulatori
role
activ
pc
also
exert
antiinflammatori
activ
inhibit
proinflammatori
cytokin
product
leukocyt
infiltr
reduc
pc
hand
increas
gener
thrombin
influenza
viru
infect
howev
complex
network
regul
coagul
contradictori
effect
pc
often
observ
lethal
influenza
mice
inhibit
inflamm
pulmonari
coagulopathi
also
facilit
neutrophil
influx
protein
leakag
bronchoalveolar
addit
antipc
antibodi
treatment
result
delay
mortal
recombin
activ
pc
treatment
affect
outcom
therefor
function
pc
influenza
viru
infect
remain
uncertain
also
known
antithrombin
iii
serin
proteas
inhibitor
produc
liver
function
anticoagul
inhibit
thrombin
well
fxa
fixa
fia
fxiia
activ
increas
heparin
bind
thrombin
directli
suppress
activ
proinflammatori
cell
leukocyt
ec
platelet
furthermor
inhibit
leukocyt
roll
adhes
activ
directli
bind
receptor
leukocyt
indirectli
endotheli
cellreleas
pgi
tether
cell
surfac
glycosaminoglycan
interest
possess
antivir
activ
hiv
hsv
hcv
antivir
activ
resid
serin
proteas
inhibitor
activ
hemagglutinin
influenza
viru
vitro
vivo
line
sever
proteas
gzma
elan
ctrl
gzmc
gzmb
upregul
lung
mice
infect
viru
treatment
serin
proteas
inhibitor
protect
mice
fatal
infect
tfpi
anoth
serin
proteas
inhibitor
present
endothelia
platelet
target
tffviia
complex
inhibit
coagul
cascad
modul
platelet
procoagul
activ
howev
function
tfpi
inflamm
viral
infect
remain
larg
unknown
anticoagul
proteas
cleav
vwf
produc
liver
stellat
cell
endotheli
cell
also
present
platelet
system
inflamm
reduc
activ
result
format
highmolecular
weight
vwf
multim
increas
platelet
activ
acut
iav
infect
reduc
level
elev
level
antibodi
associ
thrombot
thrombocytopen
purpura
markedli
high
ratio
vwf
circul
found
influenza
patient
thrombot
microangiopathi
decreas
level
might
result
influenza
virusinduc
cytokin
storm
howev
whether
take
part
initi
amplif
inflammatori
respons
unknown
coagul
resolv
fibrinolysi
process
involv
distinct
enzymat
cascad
physiolog
state
fibrinolysi
initi
three
serin
proteas
tissu
plasminogen
activ
tpa
urokinas
plasminogen
activ
upa
kallikrein
figur
upa
tpa
initi
convers
zymogen
plasminogen
serin
proteinas
plasmin
dissolv
polymer
fibrin
strand
fibrinolysi
regul
molecul
includ
plasminogen
activ
thrombinactivat
fibrinolysi
inhibitor
addit
fibrinolysi
activ
plasmin
play
critic
role
varieti
process
includ
inflamm
plasminogen
bind
differ
receptor
monocyt
macrophag
dc
immun
cell
gener
plasmin
respons
migrat
recruit
inflammatori
immun
cell
lesion
subsequ
stimul
product
proinflammatori
cytokin
chemokin
ro
fact
excess
activ
plasmin
exacerb
pathogenesi
differ
inflammatori
diseas
plasminogen
plasmin
play
critic
role
infect
influenza
virus
proteolyt
cleavag
ha
trypsinlik
proteas
respiratori
tract
process
ha
precursor
protein
two
disulfid
bondlink
subunit
essenti
step
life
cycl
requir
iav
infect
influenza
virus
use
convers
plasminogen
plasmin
latter
possess
trypsinlik
proteas
activ
cleav
ha
figur
moreov
miniplasmin
gener
sequenti
process
plasminogen
plasminogen
activ
elastas
found
epitheli
cell
bronchiol
report
process
ha
accumul
miniplasmin
cerebr
capillari
also
implic
influenza
enceph
therefor
plasminogendepend
cleavag
ha
use
influenza
virus
increas
replic
rate
infect
figur
hand
bind
na
influenza
viru
plasminogen
help
sequestr
plasminogen
cell
surfac
increas
cleavag
ha
help
dissemin
viru
effici
replic
iav
brain
mice
bind
plasminogen
na
seem
reli
uniqu
sequenc
motif
wsn
strain
activ
plasminogen
also
help
replic
influenza
viru
strain
naindepend
fashion
case
annexin
ii
host
cell
bind
plasminogen
activ
ha
cleavag
moreov
viral
ha
seem
abl
recruit
plasminogen
ha
cleavag
bacteri
staphylokinas
activ
plasminogen
plasmin
therebi
induc
cleavag
ha
viru
mechan
may
partli
explain
bacteri
infect
enhanc
influenza
infect
plasminogen
facilit
infect
iav
also
contribut
pathogen
viral
infect
fibrinolysi
fibrinogen
degrad
one
underli
mechan
plasminogendriven
lung
inflamm
mortal
blockad
plasminogen
fibrinolysi
acid
treatment
exampl
protect
mice
influenza
viru
lethal
increas
vascular
permeabl
induc
plasminogen
help
recruit
inflammatori
cell
site
iav
infect
also
contribut
inflamm
respons
plasminogen
might
also
interact
decreas
surviv
increas
lung
inflamm
influenza
infect
encod
gene
serin
proteas
inhibitor
inhibit
activ
tpa
upa
henc
fibrinolysi
figur
recent
identifi
unconvent
isg
target
extracellular
airway
proteas
inhibit
viral
glycoprotein
cleavag
reduc
infect
progeni
virus
vitro
vivo
figur
influenza
viru
infect
increas
product
ec
airway
epitheli
cell
inhibit
spread
iav
increas
express
may
protect
host
iav
infect
certain
circumst
exampl
passiv
cigarett
smoke
exposur
induc
express
promot
alveolar
epitheli
cell
apoptosi
exacerb
lung
inflamm
iav
infect
bacteri
superinfect
influenza
primarili
streptococcu
pneumonia
often
result
hospit
even
death
patient
iav
pneumonia
coinfect
mice
caus
markedli
sever
diseas
hyperactiv
coagul
compar
iav
infect
alon
widespread
pulmonari
thrombosi
extens
express
tf
endotheli
epitheli
immun
cell
found
lung
section
pneumoniaeposit
autopsi
coinfect
mice
secondari
pneumonia
infect
held
account
overexpress
tf
initi
coagul
cascad
thrombu
format
contribut
sever
hypoxia
death
unlik
pathogen
bacteri
superinfect
colon
commens
bacteria
pretreat
probiot
bacteria
dampen
influenzamedi
acut
lung
injuri
staphylococcu
aureu
one
common
commens
bacterium
colon
airway
induc
polar
alveolar
macrophag
inhibit
lethal
inflammatori
respons
iav
infect
furthermor
oral
nasal
pretreat
probiot
lactic
acid
bacteria
strain
lactobacillu
rhamnosu
protect
mice
lethal
pretreat
l
rhamnosu
significantli
reduc
coagulatori
activ
mainli
downregul
tf
restor
thrombomodulin
level
taken
togeth
studi
show
bacteria
airway
affect
outcom
iav
pneumonia
precis
target
bacteria
consid
treatment
influenza
influenza
viru
infect
caus
excess
activ
ec
platelet
trigger
coagul
cascad
concurr
impair
anticoagulatori
fibrinolyt
signal
procoagul
state
caus
hemorrhag
fever
often
associ
ard
sever
flu
patient
aberr
coagul
system
contribut
sever
influenza
multipl
level
activ
ec
platelet
first
produc
proinflammatori
cytokin
chemokin
enhanc
inflammatori
cell
infiltr
increas
vascular
permeabl
platelet
activ
circumst
second
coagul
factor
activ
augment
inflamm
via
par
ec
platelet
leukocyt
third
express
anticoagul
compon
decreas
ec
activ
last
fibrinolyt
proteas
plasmin
activ
upregul
coagul
hijack
influenza
viru
viral
replic
infect
understand
cellular
molecular
event
coagul
contribut
develop
precis
therapeut
iav
infect
drug
target
endotheli
cell
activ
agonist
antiplatelet
agent
eptifibatid
aspirin
mr
clopidogrel
anticoagul
recombin
activ
pc
ancrod
proteas
inhibitor
aprotinin
effect
hamper
pathogen
iav
infect
mice
nevertheless
detail
mechan
coagul
contribut
pathogenesi
sever
influenza
especi
human
remain
investig
better
understand
coagulatori
homeostasi
would
definit
benefit
develop
precis
treatment
epidem
pandem
influenza
